Jia, Bo
Dong, Zhi
Wu, Di
Zhao, Jun
Wu, Meina
An, Tongtong
Wang, Yuyan
Zhuo, Minglei
Li, Jianjie
Wang, Yang
Zhang, Jie
Zhao, Xinghui
Li, Sheng
Li, Junfeng
Ma, Menglei
Chen, Chen
Yang, Xue
Zhong, Jia
Chen, Hanxiao
Wang, Jingjing
Chi, Yujia
Zhai, Xiaoyu
Cui, Song
Zhang, Rong
Ma, Qingwei
Fang, Jian
Wang, Ziping http://orcid.org/0000-0002-6763-7431
Funding for this research was provided by:
Science Foundation of Peking University Cancer Hospital (18-02)
Capital Clinical Characteristics and Application Research (Z181100001718104)
Beijing Excellent Talent Cultivation Subsidy Young Backbone Individual Project (2018000021469G264)
Article History
Received: 4 July 2020
Accepted: 18 November 2020
First Online: 9 December 2020
Ethics approval and consent to participate
: The study was approved by the Medical Ethics Committee of Peking University Cancer Hospital. All patients signed “Informed consent of obtaining the patient sample to conduct a scientific study” and all authors had no access to patient’s identities.
: All authors have read and agreed to the published version of the manuscript.
: Authors Song Cui, Rong Zhang, Qingwei Ma were employed by the company Bioyong Technologies Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.